Related references
Note: Only part of the references are listed.Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15
Tyler B. Faust et al.
NATURE CHEMICAL BIOLOGY (2020)
pSILAC method coupled with two complementary digestion approaches reveals PRPF39 as a new E7070-dependent DCAF15 substrate
Xinglong Jia et al.
JOURNAL OF PROTEOMICS (2020)
Optical Control of Small Molecule-Induced Protein Degradation
Yuta Naro et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complex
Dirksen E. Bussiere et al.
NATURE CHEMICAL BIOLOGY (2020)
Light-induced control of protein destruction by opto-PROTAC
Jing Liu et al.
SCIENCE ADVANCES (2020)
A Small Molecule-Controlled Cas9 Repressible System
Youjun Wu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Azo-PROTAC: Novel Light-Controlled Small-Molecule Tool for Protein Knockdown
Yu-Hui Jin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Combining scaling relationships overcomes rate versus overpotential trade-offs in O2 molecular electrocatalysis
Daniel J. Martin et al.
SCIENCE ADVANCES (2020)
Exploring Targeted Degradation Strategy for Oncogenic KRASG12C
Mei Zeng et al.
CELL CHEMICAL BIOLOGY (2020)
Chaperone-mediated autophagy: Advances from bench to bedside
Wenming Li et al.
NEUROBIOLOGY OF DISEASE (2019)
Development of Dual and Selective Degraders of Cyclin-Dependent Kinases 4 and 6
Baishan Jiang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Peptidic degron for IMiD-induced degradation of heterologous proteins
Vidyasagar Koduri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications
Carl C. Ward et al.
ACS CHEMICAL BIOLOGY (2019)
Rapid and Reversible Knockdown of Endogenously Tagged Endosomal Proteins via an Optimized HaloPROTAC Degrader
Hannah Tovell et al.
ACS CHEMICAL BIOLOGY (2019)
Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis
Soumik BasuRay et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
HsSAS-6-dependent cartwheel assembly ensures stabilization of centriole intermediates
Satoko Yoshiba et al.
JOURNAL OF CELL SCIENCE (2019)
Harnessing the anti-cancer natural product nimbolide for targeted protein degradation
Jessica N. Spradlin et al.
NATURE CHEMICAL BIOLOGY (2019)
BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design
William Farnaby et al.
NATURE CHEMICAL BIOLOGY (2019)
Electrophilic PROTACs that degrade nuclear proteins by engaging DCAF16
Xiaoyu Zhang et al.
NATURE CHEMICAL BIOLOGY (2019)
An efficient auxin-inducible degron system with low basal degradation in human cells
Shiqian Li et al.
NATURE METHODS (2019)
Illustrate: Software for Biomolecular Illustration
David S. Goodsell et al.
STRUCTURE (2019)
Reversible Spatiotemporal Control of Induced Protein Degradation by Bistable PhotoPROTACs
Patrick Pfaff et al.
ACS CENTRAL SCIENCE (2019)
Light-Induced Protein Degradation with Photocaged PROTACs
Gang Xue et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Structural Basis and Kinetic Pathway of RBM39 Recruitment to DCAF15 by a Sulfonamide Molecular Glue E7820
Xinlin Du et al.
STRUCTURE (2019)
Aryl Sulfonamides Degrade RBM39 and RBM23 by Recruitment to CRL4-DCAF15
Tabitha C. Ting et al.
CELL REPORTS (2019)
Condensin locates at transcriptional termination sites in mitosis, possibly releasing mitotic transcripts
Norihiko Nakazawa et al.
OPEN BIOLOGY (2019)
Degron mediated BRM/SMARCA2 depletion uncovers novel combination partners for treatment of BRG1/SMARCA4-mutant cancers
Florencia Rago et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
MDM2-Recruiting PROTAC Offers Superior, Synergistic Antiproliferative Activity via Simultaneous Degradation of BRD4 and Stabilization of p53
John Hines et al.
CANCER RESEARCH (2019)
Chk1-mediated Cdc25A degradation as a critical mechanism for normal cell cycle progression
Hidemasa Goto et al.
JOURNAL OF CELL SCIENCE (2019)
AUTACs: Cargo-Specific Degraders Using Selective Autophagy
Daiki Takahashi et al.
MOLECULAR CELL (2019)
PROTAC-Mediated Degradation of Bruton's Tyrosine Kinase Is Inhibited by Covalent Binding
Christopher P. Tinworth et al.
ACS CHEMICAL BIOLOGY (2019)
SPR-Measured Dissociation Kinetics of PROTAC Ternary Complexes Influence Target Degradation Rate
Michael J. Roy et al.
ACS CHEMICAL BIOLOGY (2019)
Homolog-Selective Degradation as a Strategy to Probe the Function of CDK6 in AML
Matthias Brand et al.
CELL CHEMICAL BIOLOGY (2019)
Protac-Induced Protein Degradation in Drug Discovery: Breaking the Rules or Just Making New Ones?
Ian Churcher
JOURNAL OF MEDICINAL CHEMISTRY (2018)
A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos
Mary E. Matyskiela et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Development of the first small molecule histone deacetylase 6 (HDAC6) degraders
Ka Yang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Phthalimide conjugations for the degradation of oncogenic PI3K
Wenlu Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
In Vivo Assessment of the Effect of CYP1A2 Inhibition and Induction on Pomalidomide Pharmacokinetics in Healthy Subjects
Yan Li et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Demonstrating In-Cell Target Engagement Using a Pirin Protein Degradation Probe (CCT367766)
Nicola E. A. Chessum et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
The dTAG system for immediate and target-specific protein degradation
Behnam Nabet et al.
NATURE CHEMICAL BIOLOGY (2018)
Plasticity in binding confers selectivity in ligand-induced protein degradation
Radoslaw P. Nowak et al.
NATURE CHEMICAL BIOLOGY (2018)
A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment
Marc L. Hyer et al.
NATURE MEDICINE (2018)
Modulating PCAF/GCN5 Immune Cell Function through a PROTAC Approach
Zuni I. Bassi et al.
ACS CHEMICAL BIOLOGY (2018)
Quantitative Live-Cell Kinetic Degradation and Mechanistic Profiling of PROTAC Mode of Action
Kristin M. Riching et al.
ACS CHEMICAL BIOLOGY (2018)
CrbnI391V is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in mice
Emma C. Fink et al.
BLOOD (2018)
Mutant NPM1 Maintains the Leukemic State through HOX Expression
Lorenzo Brunetti et al.
CANCER CELL (2018)
SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate
Mary E. Matyskiela et al.
NATURE CHEMICAL BIOLOGY (2018)
Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome
Katherine A. Donovan et al.
ELIFE (2018)
Transcription Factors Activate Genes through the Phase-Separation Capacity of Their Activation Domains
Ann Boija et al.
CELL (2018)
Enhancing Antiproliferative Activity and Selectivity of a FLT-3 Inhibitor by Proteolysis Targeting Chimera Conversion
George M. Burslem et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Humanized cereblon mice revealed two distinct therapeutic pathways of immunomodulatory drugs
Yohannes Gemechu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN
Quinlan L. Sievers et al.
SCIENCE (2018)
A Chemoproteomic Approach to Query the Degradable Kinome Using a Multi-kinase Degrader
Hai-Tsang Huang et al.
CELL CHEMICAL BIOLOGY (2018)
Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead
Daniel P. Bondeson et al.
CELL CHEMICAL BIOLOGY (2018)
The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study
George M. Burslem et al.
CELL CHEMICAL BIOLOGY (2018)
Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance
Jemilat Salami et al.
COMMUNICATIONS BIOLOGY (2018)
Clinical Pharmacokinetics and Pharmacodynamics of Lenalidomide
Nianhang Chen et al.
CLINICAL PHARMACOKINETICS (2017)
Transcription control by the ENL YEATS domain in acute leukaemia
Michael A. Erb et al.
NATURE (2017)
Selective degradation of splicing factor CAPERα by anticancer sulfonamides
Taisuke Uehara et al.
NATURE CHEMICAL BIOLOGY (2017)
Structural basis of PROTAC cooperative recognition for selective protein degradation
Morgan S. Gadd et al.
NATURE CHEMICAL BIOLOGY (2017)
Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15
Ting Han et al.
SCIENCE (2017)
Waste disposal-An attractive strategy for cancer therapy
Jemilat Salami et al.
SCIENCE (2017)
MELK is not necessary for the proliferation of basal-like breast cancer cells
Hai-Tsang Huang et al.
ELIFE (2017)
A Method for the Acute and Rapid Degradation of Endogenous Proteins
Dean Clift et al.
CELL (2017)
Small-Molecule Modulation of Protein Homeostasis
George M. Burslem et al.
CHEMICAL REVIEWS (2017)
A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase
Mary E. Matyskiela et al.
NATURE (2016)
Structural basis of lenalidomide-induced CK1α degradation by the CRL4CRBN ubiquitin ligase
Georg Petzold et al.
NATURE (2016)
Targeted inhibition of the COP9 signalosome for treatment of cancer
Anita Schlierf et al.
NATURE COMMUNICATIONS (2016)
HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of Halo Tag Fusion Proteins
Dennis L. Buckley et al.
ACS CHEMICAL BIOLOGY (2015)
CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL
Patrick R. Hagner et al.
BLOOD (2015)
Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein Homeostasis
Daniel J. Anderson et al.
CANCER CELL (2015)
Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4
Jing Lu et al.
CHEMISTRY & BIOLOGY (2015)
Tunable and reversible drug control of protein production via a self-excising degron
Hokyung K. Chung et al.
NATURE CHEMICAL BIOLOGY (2015)
Catalytic in vivo protein knockdown by small-molecule PROTACs
Daniel P. Bondeson et al.
NATURE CHEMICAL BIOLOGY (2015)
Degradation of HaloTag-fused nuclear proteins using bestatin-HaloTag ligand hybrid molecules
Shusuke Tomoshige et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2015)
Phthalimide conjugation as a strategy for in vivo target protein degradation
Georg E. Winter et al.
SCIENCE (2015)
Engineering FKBP-Based Destabilizing Domains to Build Sophisticated Protein Regulation Systems
Wenlin An et al.
PLOS ONE (2015)
Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4CRBN
Anita K. Gandhi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Structure of the DDBI-CRBN E3 ubiquitin ligase in complex with thalidomide
Eric S. Fischer et al.
NATURE (2014)
Targeted protein destabilization reveals an estrogen-mediated ER stress response
Kanak Raina et al.
NATURE CHEMICAL BIOLOGY (2014)
Rapid and reversible knockdown of endogenous proteins by peptide-directed lysosomal degradation
Xuelai Fan et al.
NATURE NEUROSCIENCE (2014)
Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
Jan Kroenke et al.
SCIENCE (2014)
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
Gang Lu et al.
SCIENCE (2014)
Lenalidomide induces degradation of IKZF1 and IKZF3
Jan Kroenke et al.
ONCOIMMUNOLOGY (2014)
A LOV2 Domain-Based Optogenetic Tool to Control Protein Degradation and Cellular Function
Christian Renicke et al.
CHEMISTRY & BIOLOGY (2013)
Targeting the von Hippel-Lindau E3 Ubiquitin Ligase Using Small Molecules To Disrupt the VHL/HIF-1α Interaction
Dennis L. Buckley et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Fluorescent fusion protein knockout mediated by anti-GFP nanobody
Emmanuel Caussinus et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
The application and biology of immunomodulatory drugs (IMiDs) in cancer
Beiqing Pan et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Global Identification of Modular Cullin-RING Ligase Substrates
Michael J. Emanuele et al.
CELL (2011)
Small-molecule hydrophobic tagging-induced degradation of HaloTag fusion proteins
Taavi K. Neklesa et al.
NATURE CHEMICAL BIOLOGY (2011)
Protein Knockdown Using Methyl Bestatin-Ligand Hybrid Molecules: Design and Synthesis of Inducers of Ubiquitination-Mediated Degradation of Cellular Retinoic Acid-Binding Proteins
Yukihiro Itoh et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Jasmonate perception by inositol-phosphate-potentiated COI1-JAZ co-receptor
Laura B. Sheard et al.
NATURE (2010)
Identification of a Primary Target of Thalidomide Teratogenicity
Takumi Ito et al.
SCIENCE (2010)
Efficient protection and isolation of ubiquitylated proteins using tandem ubiquitin-binding entities
Roland Hjerpe et al.
EMBO REPORTS (2009)
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
Teresa A. Soucy et al.
NATURE (2009)
An auxin-based degron system for the rapid depletion of proteins in nonplant cells
Kohei Nishimura et al.
NATURE METHODS (2009)
Regulated expression of the Leishmania major surface virulence factor lipophosphoglycan using conditionally destabilized fusion proteins
Luciana Madeira da Silva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
HatoTag: A novel protein labeling technology for cell imaging and protein analysis
Georgyi V. Los et al.
ACS CHEMICAL BIOLOGY (2008)
Structural elements of the ubiquitin-independent proteasome degron of ornithine decarboxylase
Junko Takeuchi et al.
BIOCHEMICAL JOURNAL (2008)
An FKBP destabilization domain modulates protein levels in Plasmodium falciparum
Christopher M. Armstrong et al.
NATURE METHODS (2007)
Mechanism of auxin perception by the TIR1 ubiquitin ligase
Xu Tan et al.
NATURE (2007)
A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules
Laura A. Banaszynski et al.
CELL (2006)
Intracellular protein degradation: From a vague idea, through the lysosome and the ubiquitin-proteasome system, and onto human diseases and drug targeting - (Nobel lecture)
A Ciechanover
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2005)
Thalidomide in the treatment of leprosy
SK Teo et al.
MICROBES AND INFECTION (2002)
Auxin regulates SCFTIR1-dependent degradation of AUX/IAA proteins
WM Gray et al.
NATURE (2001)
Protacs: Chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation
KM Sakamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Interactions of the COP9 signalosome with the E3 ubiquitin ligase SCFTIR1 in mediating auxin response
C Schwechheimer et al.
SCIENCE (2001)
Current role of thalidomide in cancer treatment
DA Thomas et al.
CURRENT OPINION IN ONCOLOGY (2000)
Share Paper
